Hepatitis C in Wisconsin Jails: Barriers to Testing and Treatment During Incarceration.

BACKGROUND

Justice-involved individuals are disproportionately affected by hepatitis C virus (HCV) infection. Wisconsin's viral hepatitis elimination plan prioritizes this population, yet little is known about jail capacity for testing and treatment.

METHODS

A 10-item survey was emailed to administrators of 71 county jails and 1 Tribal detention facility to assess HCV testing and treatment practices and barriers. Responses were analyzed descriptively.

RESULTS

Thirty facilities (41.7%) responded. Ten jails (33.3%) offered HCV testing; 15 (51.7%) provided treatment. Common barriers to testing included lack of contracted services (40%) and staffing constraints (23.3%). Barriers to treatment included financial restrictions (66.7%) and short incarceration periods (33.3%).

DISCUSSION: Limited testing and treatment capacity persists despite Medicaid coverage and effective therapies.

CONCLUSIONS

Partnerships with local health agencies and policy changes addressing cost and contractual limitations are essential to expand HCV services in Wisconsin jails.